The 'Which option to slow myopia' is a world first, evidence based decision making tool, providing guidance on selecting the right treatment for your young myopic patient. Our international focus group testing, prior to release, means we’re confident you’ll find this tool extremely useful in clinical practice.
Spectacle lens options are often the first choice for the younger patient, or the only choice for a child not suitable for contact lens wear. This section of the infographic provides prescribing selection based on evidence of efficacy based on binocular vision status.
Contact lens options
Specific considerations in fitting myopia controlling contact lenses include safety, astigmatism, level of myopia and binocular vision status. Even if you don't have access to all of these options in your country or practice, you'll find a management pathway in this infographic.
Myopia management is a long term process - how do you know it's working? This section of the infographic elegantly summarises the average amount of myopia progression we'd expect to measure each year, by age, if employing no myopia management strategy (0% efficacy), multifocal spectacles (around 33% efficacy) or multifocal contact lenses including OrthoK (50% efficacy). Atropine is not included as its efficacy appears to be dose-dependent.